{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:30:20Z","timestamp":1793107820719,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022752","name":"MSD Sharp & Dohme GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jmii.2025.08.020","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T23:10:38Z","timestamp":1756336238000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Longitudinal molecular epidemiology of ceftriaxone-resistant enterobacterales in intra-abdominal and urinary tract infections: A decade-long SMART surveillance study in Taiwan (2009\u20132019)"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1510-5936","authenticated-orcid":false,"given":"Yu-Hsun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Eng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Der","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ming","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-1870","authenticated-orcid":false,"given":"Ya-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2025.08.020_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.25122\/jml-2023-0404","article-title":"The burden of antibiotic resistance of the main microorganisms causing infections in humans - review of the literature","volume":"17","author":"Baciu","year":"2024","journal-title":"J Med Life"},{"key":"10.1016\/j.jmii.2025.08.020_bib2","series-title":"WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance","year":"2024"},{"key":"10.1016\/j.jmii.2025.08.020_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01076-18","article-title":"Past and present perspectives on beta-lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.08.020_bib4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jmii.2025.08.020_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab387","volume":"8","author":"Stewart","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.020_bib6","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1128\/AAC.00426-09","article-title":"Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative Bacilli in the Asia-Pacific region: data from the study for monitoring antimicrobial resistance trends (SMART) program, 2007","volume":"53","author":"Hawser","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.08.020_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jac\/dkw398","volume":"72","author":"Jean","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.08.020_bib8","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/AAC.00971-12","volume":"57","author":"Sheng","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.08.020_bib9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/ph6111335","article-title":"A review of ten years of the study for monitoring antimicrobial resistance trends (SMART) from 2002 to 2011","volume":"6","author":"Morrissey","year":"2013","journal-title":"Pharmaceuticals"},{"issue":"Suppl","key":"10.1016\/j.jmii.2025.08.020_bib10","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0924-8579(12)70007-9","volume":"40","author":"Lee","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.08.020_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ijantimicag.2017.01.030","article-title":"Epidemiology and trends in the antibiotic susceptibilities of Gram-negative Bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013","volume":"49","author":"Chang","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.08.020_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2016.01.008","article-title":"Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: results from the study for monitoring antimicrobial resistance trends (SMART), 2010-2013","volume":"47","author":"Jean","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.08.020_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jmii.2021.07.015","article-title":"Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018","volume":"55","author":"Jean","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2025.08.020_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jmii.2025.08.020_bib15","series-title":"Performance Standards for Antimicrobial Susceptibility Testing. 34th Ed. CLSI Supplement M100","year":"2024"},{"key":"10.1016\/j.jmii.2025.08.020_bib16","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","article-title":"Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR","volume":"40","author":"P\u00e9rez-P\u00e9rez","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2025.08.020_bib17","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/AAC.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013","volume":"59","author":"Lob","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2025.08.020_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12941-024-00700-8","article-title":"Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and enterobacter cloacae: a multicentre cohort study","volume":"23","author":"Guedes","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jmii.2025.08.020_bib19","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/ofid\/ofy347","article-title":"Variations in the occurrence of resistance phenotypes and carbapenemase genes among enterobacteriaceae isolates in 20 years of the SENTRY antimicrobial surveillance program","volume":"6","author":"Castanheira","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.020_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115512","article-title":"Trends of major antimicrobial resistance phenotypes in Enterobacterales and gram-negative non-fermenters from ATLAS and EARS-Net surveillance systems: italian vs. European and global data, 2008-2018","volume":"101","author":"Rossolini","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.020_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jgar.2021.02.031","article-title":"Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016-2018 from USA and Europe: genotypic analysis of beta-lactamases and comparative in vitro activity of cefepime\/enmetazobactam","volume":"25","author":"Belley","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"Suppl","key":"10.1016\/j.jmii.2025.08.020_bib22","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0924-8579(12)70008-0","article-title":"Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the study for monitoring antimicrobial resistance trends (SMART)","volume":"40","author":"Lu","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.08.020_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106815","article-title":"In vitro activity of imipenem\/relebactam, meropenem\/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the study for monitoring antimicrobial resistance trends (SMART), 2020","volume":"61","author":"Chang","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.08.020_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8010008","article-title":"Detection of plasmid-mediated beta-lactamase genes and emergence of a novel AmpC (CMH-1) in Enterobacter cloacae at a medical center in southern Taiwan","volume":"8","author":"Ku","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.jmii.2025.08.020_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz353","article-title":"Molecular epidemiology of ceftriaxone non-susceptible Enterobacterales isolates in an academic medical center in the United States","volume":"6","author":"Tamma","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.020_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/jac\/dkx466","article-title":"Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27","volume":"73","author":"Harris","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.08.020_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2021.101647","article-title":"In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019","volume":"25","author":"Karlowsky","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.020_bib28","article-title":"Antibiotic resistance in enterobacteriaceae: mechanisms and clinical implications","volume":"352","author":"Iredell","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jmii.2025.08.020_bib29","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/cid\/cix034","article-title":"The use of noncarbapenem beta-lactams for the treatment of extended-spectrum beta-lactamase infections","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.020_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s15010-019-01291-9","article-title":"AmpC beta-lactamase-producing enterobacterales: what a clinician should know","volume":"47","author":"Meini","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.jmii.2025.08.020_bib31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/QCO.0000000000000789","article-title":"Role of new antibiotics in extended-spectrum beta-lactamase-, AmpC- infections","volume":"34","author":"Bassetti","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jmii.2025.08.020_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33114","article-title":"Ceftolozane\/Tazobactam: literature review of its activity on Taiwanese isolates before its launch in Taiwan (2012-2021)","volume":"10","author":"Chao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jmii.2025.08.020_bib33","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/jac\/dkx136","article-title":"Activity of ceftolozane\/tazobactam against surveillance and 'problem' enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British isles","volume":"72","author":"Livermore","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2025.08.020_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijantimicag.2017.09.016","volume":"51","author":"Pfaller","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.08.020_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jgar.2025.02.001","article-title":"In vitro activity of ceftolozane\/tazobactam against ESBL-Producing Enterobacterales in China: SMART 2016-2019","volume":"42","author":"Yu","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jmii.2025.08.020_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01258-24","article-title":"Molecular epidemiology of beta-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States","volume":"69","author":"Hareza","year":"2025","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:12:16Z","timestamp":1772892736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1684118225001793"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.08.020","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal molecular epidemiology of ceftriaxone-resistant enterobacterales in intra-abdominal and urinary tract infections: A decade-long SMART surveillance study in Taiwan (2009\u20132019)","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}